Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

Abstract:

:Current dendritic cell (DC)-based vaccines are based on ex vivo-generated autologous DCs loaded with antigen prior to readministration into patients. A more direct and less laborious strategy is to target antigens to DCs in vivo via specific surface receptors. Therefore, we developed a humanized antibody, hD1V1G2/G4 (hD1), directed against the C-type lectin DC-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) to explore its capacity to serve as a target receptor for vaccination purposes. hD1 was cross-linked to a model antigen, keyhole limpet hemocyanin (KLH). We observed that the chimeric antibody-protein complex (hD1-KLH) bound specifically to DC-SIGN and was rapidly internalized and translocated to the lysosomal compartment. To determine the targeting efficiency of hD1-KLH, monocyte-derived DCs and peripheral blood lymphocytes (PBLs) were obtained from patients who had previously been vaccinated with KLH-pulsed DCs. Autologous DCs pulsed with hD1-KLH induced proliferation of patient PBLs at a 100-fold lower concentration than KLH-pulsed DCs. In addition, hD1-KLH-targeted DCs induced proliferation of naive T cells recognizing KLH epitopes in the context of major histocompatibility complex (MHC) classes I and II. We conclude that antibody-mediated targeting of antigen to DCs via DC-SIGN effectively induces antigen-specific naive as well as recall T-cell responses. This identifies DC-SIGN as a promising target molecule for DC-based vaccination strategies.

journal_name

Blood

journal_title

Blood

authors

Tacken PJ,de Vries IJ,Gijzen K,Joosten B,Wu D,Rother RP,Faas SJ,Punt CJ,Torensma R,Adema GJ,Figdor CG

doi

10.1182/blood-2005-01-0318

subject

Has Abstract

pub_date

2005-08-15 00:00:00

pages

1278-85

issue

4

eissn

0006-4971

issn

1528-0020

pii

2005-01-0318

journal_volume

106

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells.

    abstract::Human immunodeficiency virus-1 (HIV-1)-Tat, the transactivating gene product of HIV-1, has been shown to interact with different cell types, inducing gene expression, altering their growth and migratory behavior. In this study we examined whether Tat might affect functions of acquired immunodeficiency syndrome (AIDS)-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chirivi RG,Taraboletti G,Bani MR,Barra L,Piccinini G,Giacca M,Bussolino F,Giavazzi R

    更新日期:1999-09-01 00:00:00

  • Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates.

    abstract::Photochemical decontamination (PCD) of platelet concentrates, with adequate preservation of platelet function, has been shown using 8-methoxypsoralen (8-MOP) and long wavelength UV light (UVA). To further evaluate this technique, models for the inactivation of pathogenic human cell-associated viruses and integrated pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lin L,Londe H,Hanson CV,Wiesehahn G,Isaacs S,Cimino G,Corash L

    更新日期:1993-07-01 00:00:00

  • Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice.

    abstract::The glycoprotein CD47 (integrin-associated protein, IAP) is present on the surface of virtually all cells, including red blood cells (RBCs). CD47 acts like a marker of self by ligating the macrophage inhibitory receptor signal regulatory protein alpha (SIRPalpha). In this manner mild reactivity of wild-type RBCs with ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3500

    authors: Oldenborg PA,Gresham HD,Chen Y,Izui S,Lindberg FP

    更新日期:2002-05-15 00:00:00

  • Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.

    abstract::Recombinant human macrophage colony-stimulating factor (rhM-CSF) was given to cynomolgus monkeys by continuous intravenous infusion or subcutaneous injection, at a dose of 50 to 100 micrograms/kg/d in repetitive 14-day cycles. Starting within 24 to 48 hours of initiation of rhM-CSF, there was a progressive increase in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Munn DH,Garnick MB,Cheung NK

    更新日期:1990-05-15 00:00:00

  • Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation.

    abstract::Eighteen patients with relapse of chronic myelogenous leukemia (CML) after allogeneic bone marrow transplantation (BMT) were treated with recombinant human alpha 2a interferon (IFN). Relapse was defined as greater than 90% metaphases containing the Philadelphia chromosome (Ph) and hematologic abnormalities consistent ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Higano CS,Raskind WH,Singer JW

    更新日期:1992-09-15 00:00:00

  • Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.

    abstract::Fibrinogen was isolated from the plasma of a 25-year-old female with a history of mild bleeding and several recent moderate to severe hemorrhagic episodes. Coagulability with thrombin approached 100% and varied directly with the time of incubation with the enzyme. High-performance liquid chromatography analysis of thr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Siebenlist KR,Prchal JT,Mosesson MW

    更新日期:1988-03-01 00:00:00

  • Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells.

    abstract::Translocations in myeloma are thought to occur solely in mature B cells in the germinal center through class switch recombination (CSR). We used a targeted captured technique followed by massively parallel sequencing to determine the exact breakpoints in both the immunoglobulin heavy chain (IGH) locus and the partner ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-471888

    authors: Walker BA,Wardell CP,Johnson DC,Kaiser MF,Begum DB,Dahir NB,Ross FM,Davies FE,Gonzalez D,Morgan GJ

    更新日期:2013-04-25 00:00:00

  • Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

    abstract::Severe aplastic anemia (SAA) can be successfully treated with allogeneic bone marrow transplantation (BMT) or immunosuppressive therapy. However, the majority of patients with SAA are not eligible for BMT because they lack an HLA-identical sibling. Conventional immunosuppressive therapy also has major limitations; man...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Brodsky RA,Sensenbrenner LL,Jones RJ

    更新日期:1996-01-15 00:00:00

  • Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.

    abstract::Daratumumab, a monoclonal CD38 antibody, is approved in the treatment of myeloma, but its efficacy and safety in light-chain (AL) amyloidosis has not been formally studied. This prospective phase 2 trial of daratumumab monotherapy for the treatment of AL amyloidosis was designed to determine the safety, tolerability, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004436

    authors: Sanchorawala V,Sarosiek S,Schulman A,Mistark M,Migre ME,Cruz R,Sloan JM,Brauneis D,Shelton AC

    更新日期:2020-04-30 00:00:00

  • Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.

    abstract::Histone deacetylase (HDAC) enzymatic activity has been linked to the transcription of DNA in cancers including multiple myeloma (MM). Therefore, HDAC inhibitors used alone and in combination are being actively studied as novel therapies in MM. In the present study, we investigated the preclinical activity of ACY-1215,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387365

    authors: Santo L,Hideshima T,Kung AL,Tseng JC,Tamang D,Yang M,Jarpe M,van Duzer JH,Mazitschek R,Ogier WC,Cirstea D,Rodig S,Eda H,Scullen T,Canavese M,Bradner J,Anderson KC,Jones SS,Raje N

    更新日期:2012-03-15 00:00:00

  • Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.

    abstract::We aimed to determine the prognostic impact of monosomal karyotype (MK) in acute myeloid leukemia (AML) in the context of the current World Health Organization (WHO) classification and to evaluate the outcome of MK(+) patients after allogeneic HSCT. Of 1058 patients with abnormal cytogenetics, 319 (30%) were MK MK(+)....

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-07-367508

    authors: Kayser S,Zucknick M,Döhner K,Krauter J,Köhne CH,Horst HA,Held G,von Lilienfeld-Toal M,Wilhelm S,Rummel M,Germing U,Götze K,Nachbaur D,Schlegelberger B,Göhring G,Späth D,Morlok C,Teleanu V,Ganser A,Döhner H,Schlenk

    更新日期:2012-01-12 00:00:00

  • Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cells.

    abstract::Caveolin-1 (Cav-1) is a key organizer of membrane specializations and a scaffold protein that regulates signaling in multiple cell types. We found increased Cav-1 expression in human and murine T cells after allogeneic hematopoietic cell transplantation. Indeed, Cav-1(-/-)donor T cells caused less severe acute graft-v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672428

    authors: Schönle A,Hartl FA,Mentzel J,Nöltner T,Rauch KS,Prestipino A,Wohlfeil SA,Apostolova P,Hechinger AK,Melchinger W,Fehrenbach K,Guadamillas MC,Follo M,Prinz G,Ruess AK,Pfeifer D,del Pozo MA,Schmitt-Graeff A,Duyster J,H

    更新日期:2016-04-14 00:00:00

  • Analysis of fibrinogen gamma-chain truncations shows the C-terminus, particularly gammaIle387, is essential for assembly and secretion of this multichain protein.

    abstract::To examine the role of the fibrinogen gamma chain in the assembly and secretion of this multichain protein, we synthesized a series of fibrinogen variants with truncated gamma chains, terminating between residues gamma379 and the C-terminus, gamma411. The variant fibrinogens were synthesized from altered gamma-chain c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3654

    authors: Okumura N,Terasawa F,Tanaka H,Hirota M,Ota H,Kitano K,Kiyosawa K,Lord ST

    更新日期:2002-05-15 00:00:00

  • Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.

    abstract::Graft-versus-host disease (GVHD) is a systemic inflammatory response due to the recognition of major histocompatibility complex disparity between donor and recipient after hematopoietic stem cell transplantation (HSCT). T-cell activation is critical to the induction of GVHD, and data from our group and others have sho...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-09-526020

    authors: Lin KL,Fulton LM,Berginski M,West ML,Taylor NA,Moran TP,Coghill JM,Blazar BR,Bear JE,Serody JS

    更新日期:2014-03-06 00:00:00

  • Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.

    abstract::Chronic myeloid leukemia (CML) is a malignant disorder of the hematopoietic stem cell. It has been shown that normal stem cells coexist with malignant stem cells in the bone marrow of patients with chronic-phase CML. To characterize the primitive hematopoietic progenitor cells within CML marrow, CD34+DR- and CD34+DR+ ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Leemhuis T,Leibowitz D,Cox G,Silver R,Srour EF,Tricot G,Hoffman R

    更新日期:1993-02-01 00:00:00

  • Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia.

    abstract::Glanzmann's thrombasthenia is an inherited bleeding disorder characterized by abnormalities of platelet membrane glycoproteins (GP) IIb and IIIa. Most patients, usually designated as type I, have been reported to have undetectable levels of GP IIb and GP IIIa with the assay used. We have used polyclonal rabbit antibod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nurden AT,Didry D,Kieffer N,McEver RP

    更新日期:1985-04-01 00:00:00

  • Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

    abstract::Inhibition of the tissue factor pathway has been shown to attenuate the activation of coagulation and to prevent death in a gram-negative bacteremia primate model of sepsis. It has been suggested that tissue factor influences inflammatory cascades other than the coagulation system. The authors sought to determine the ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: de Jonge E,Dekkers PE,Creasey AA,Hack CE,Paulson SK,Karim A,Kesecioglu J,Levi M,van Deventer SJ,van Der Poll T

    更新日期:2000-02-15 00:00:00

  • Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein.

    abstract::Using thiol deprivation, we have previously shown that the response of natural killer (NK) cells to interleukin-2 (IL-2) is subject to redox regulation downstream of IL-2 binding and internalization. We have now used the IL-2-dependent cell line, NK3.3 to study redox regulation of NK cells further, and found that NK3....

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yamauchi A,Bloom ET

    更新日期:1997-06-01 00:00:00

  • The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.

    abstract::Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and a susceptibility to leukemia. There are at least 8 complementation groups (A through H). Extensive analyses of the FA group C gene FANCC in Western countries revealed that 10% to 15% of FA patients have mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Futaki M,Yamashita T,Yagasaki H,Toda T,Yabe M,Kato S,Asano S,Nakahata T

    更新日期:2000-02-15 00:00:00

  • SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.

    abstract::Mantle cell lymphoma (MCL) is one of the most aggressive lymphoid neoplasms whose pathogenesis is not fully understood. The neural transcription factor SOX11 is overexpressed in most MCL but is not detected in other mature B-cell lymphomas or normal lymphoid cells. The specific expression of SOX11 in MCL suggests that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-438937

    authors: Vegliante MC,Palomero J,Pérez-Galán P,Roué G,Castellano G,Navarro A,Clot G,Moros A,Suárez-Cisneros H,Beà S,Hernández L,Enjuanes A,Jares P,Villamor N,Colomer D,Martín-Subero JI,Campo E,Amador V

    更新日期:2013-03-21 00:00:00

  • Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients.

    abstract::We report here the results of polymerase chain reaction (PCR) for bcr-abl transcript and clinical details derived from 64 chronic myelogenous leukemia (CML) patients after allogeneic bone marrow transplantation (BMT). A total of 139 samples (2 to 220 weeks after BMT) were analyzed and bcr-abl transcript was detected i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miyamura K,Tahara T,Tanimoto M,Morishita Y,Kawashima K,Morishima Y,Saito H,Tsuzuki S,Takeyama K,Kodera Y

    更新日期:1993-02-15 00:00:00

  • Second to none.

    abstract::In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-07-439158

    authors: Rajkumar SV

    更新日期:2012-08-23 00:00:00

  • Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib.

    abstract::De novo presentation of acute myeloid leukemia (AML) expressing the Philadelphia (Ph) chromosomal abnormality is rare and is associated with a dismal prognosis. To date, reported cases of Ph(+) AML have expressed either the e13a2 or e14a2 BCR-ABL fusion transcripts. We report a unique case of de novo AML expressing th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-107508

    authors: Ritchie DS,McBean M,Westerman DA,Kovalenko S,Seymour JF,Dobrovic A

    更新日期:2008-03-01 00:00:00

  • Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.

    abstract::Anaplastic large cell lymphoma (ALCL) is composed of large, frequently bizarre, cells of T- or null-cell phenotype that show a preferential sinusoidal growth pattern and consistent CD30 positivity. Whether these tumors represent a single entity or several, and what the exact cell origin, is controversial. Recently, gr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Krenacs L,Wellmann A,Sorbara L,Himmelmann AW,Bagdi E,Jaffe ES,Raffeld M

    更新日期:1997-02-01 00:00:00

  • Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.

    abstract::Children with Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL) have a poorer prognosis than do most pediatric patients with ALL. Because of this poor prognosis and the presence of the Ph chromosome, we have asked whether or not Ph + ALL involves a multipotential stem cell. We cultured hematopoietic pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tachibana N,Raimondi SC,Lauer SJ,Sartain P,Dow LW

    更新日期:1987-11-01 00:00:00

  • Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.

    abstract::The interplay between bone marrow stromal cells (BMSCs) and multiple myeloma (MM) cells performs a crucial role in MM pathogenesis by secreting growth factors, cytokines, and extracellular vesicles. Exosomes are membranous vesicles 40 to 100 nm in diameter constitutively released by almost all cell types, and they med...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-562439

    authors: Wang J,Hendrix A,Hernot S,Lemaire M,De Bruyne E,Van Valckenborgh E,Lahoutte T,De Wever O,Vanderkerken K,Menu E

    更新日期:2014-07-24 00:00:00

  • Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.

    abstract::We established a model of canine marrow autografts after 9.2 Gy total body irradiation (TBI) to study the role of class II antigens in hematopoietic stem cell growth and differentiation. Twenty dogs were given 9.2 Gy TBI, marrow, and intravenous (IV) murine anti-class II monoclonal antibody (MoAb). Infusion of 0.6 mg/...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Greinix HT,Ladiges WC,Graham TC,Maslan S,Raff RF,Sandmaier BM,Appelbaum FR,Schuening FG,Deeg HJ,Storb R

    更新日期:1991-10-15 00:00:00

  • Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.

    abstract::Concentrations of plasma fibrinopeptide A (FPA) were measured by radioimmunoassay in 50 patients with venous thromboembolism or disseminated intravascular coagulation or both. A consistent discrepancy was observed in values obtained with two anti-FPA antisera. Analysis of extracts from plasma of these patients by high...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Leeksma OC,Meijer-Huizinga F,Stoepman-van Dalen EA,van Ginkel CJ,van Aken WG,van Mourik JA

    更新日期:1986-05-01 00:00:00

  • Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.

    abstract::To assess a possible role in tumor progression, the occurrence and type of K- and N-RAS mutations were determined in purified tumor cells, including samples from patients with premalignant monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and extramedullary plasma cell (PC) tumors (ExPC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-0833

    authors: Rasmussen T,Kuehl M,Lodahl M,Johnsen HE,Dahl IM

    更新日期:2005-01-01 00:00:00

  • Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

    abstract::To further unravel the molecular pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL), we performed high-resolution array comparative genomic hybridization on diagnostic specimens from 47 children with T-ALL and identified monoallelic or biallelic LEF1 microdeletions in 11% (5 of 47) of these primary samples. A...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2009-07-234377

    authors: Gutierrez A,Sanda T,Ma W,Zhang J,Grebliunaite R,Dahlberg S,Neuberg D,Protopopov A,Winter SS,Larson RS,Borowitz MJ,Silverman LB,Chin L,Hunger SP,Jamieson C,Sallan SE,Look AT

    更新日期:2010-04-08 00:00:00